U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Medical Devices
  3. Device Advice: Comprehensive Regulatory Assistance
  4. Contact Us – Division of Industry and Consumer Education (DICE)
  5. REdI Conference
  1. Contact Us – Division of Industry and Consumer Education (DICE)

REdI Conference

The Regulatory Education for Industry (REdI) Program is a free FDA-led conference that brings together the regulatory educators from the FDA's medical product centers: Center for Drug Evaluation and Research (CDER), Center for Devices and Radiological Health (CDRH), and Center for Biologics Evaluation and Research (CBER).

Goal:

To educate the regulatory community with current information about FDA’s regulation of drugs, devices, and biologics.

Audience:

Small manufacturers, researchers, and innovators seeking to learn about how the FDA regulates drugs, devices, and biologics medical products.

Program Series and Format:

  • The conference is offered in a hybrid format, with both virtual and in-person presentations.
  • For each FDA medical product center, REdI features a plenary session that combines the themes of drugs (CDER), devices (CDRH), and biologics (CBER) regulatory policy.
  • Topics span total product lifecycle.

REdI 2024

REdI 2024 was held on May 29-30, 2024, with well over 20,000 online and in-person attendees! Recordings of the 13 CDRH sessions are available here:

You may access individual topics by selecting the chapter.

Recent REdI Programs:

Back to Top